Track record · closed signal

Gilead Sciences Inc (GILD) — closed signal from May 23, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 21, 2026.

Predicted vs. what happened

GILD price · publication thesis → realized outcomesplit-adjusted
$133.48 Published $149.85 Target $146.12 Window close $148.97 Peak
$128.31 – $134.23Entry zone — fair-value band
$133.48Published — price the day we called it
$149.85Target — the price the thesis aimed for
$148.97Peak — highest point inside the window, not a realized return
$146.12Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price
$148.97
peak on August 19, 2026 — not a realized return
Peak gain
+11.6%
peak, from the publication price
Window close
$146.12
end-of-window price, context only
Days to target
—
Window
May 23, 2026 – August 21, 2026

The thesis — published May 23, 2026

Predicted growth
+13%
over the measurement window
Target price
$149.85
the price the thesis aimed for
Entry zone
$128.31 – $134.23
the fair-value band we waited for
Price at publication
$133.48
published May 23, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Gilead is a defensive healthcare stock that just got positive regulatory news: FDA approval for a liver-disease drug and European backing for an oncology drug. Valuation and profit margins look reasonable and recent buying interest improved. Near-term gains depend on these approvals causing real forecast increases, not just headlines.

Primary drivers

  • FDA approval strengthens the liver-disease drug story
  • European support expands the cancer-drug opportunity
  • Defensive healthcare mix reduces overall risk in rallies
  • Positive momentum but insider selling tempers confidence

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All GILD signals